niacinamide has been researched along with Long QT Syndrome in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chinushi, M | 1 |
| Aizawa, Y | 2 |
| Furushima, H | 1 |
| Inuzuka, H | 1 |
| Ojima, K | 1 |
| Shibata, A | 1 |
| Sato, T | 1 |
| Hata, Y | 1 |
| Yamamoto, M | 1 |
| Morita, H | 1 |
| Mizuo, K | 1 |
| Yamanari, H | 1 |
| Saito, D | 1 |
| Ohe, T | 1 |
| Uchiyama, H | 1 |
| Yamaura, M | 1 |
| Nakayama, T | 1 |
| Arita, M | 1 |
| Shimizu, W | 1 |
| Kurita, T | 1 |
| Matsuo, K | 1 |
| Suyama, K | 1 |
| Aihara, N | 1 |
| Kamakura, S | 1 |
| Towbin, JA | 1 |
| Shimomura, K | 1 |
4 other studies available for niacinamide and Long QT Syndrome
| Article | Year |
|---|---|
Nicorandil suppresses a hump on the monophasic action potential and torsade de pointes in a patient with idiopathic long QT syndrome.
Topics: Action Potentials; Aged; Anti-Arrhythmia Agents; Female; Humans; Long QT Syndrome; Niacinamide; Nico | 1995 |
Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome.
Topics: Action Potentials; Adolescent; Anti-Arrhythmia Agents; Electrocardiography; Humans; Long QT Syndrome | 1995 |
Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. Investigator Group for K-Channel Openers and Arrhythmias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Dose-Response Relationship, D | 1998 |
Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Child; Electrophysiology; Epinephrine; Female; Humans; Lo | 1998 |